BMJ Best Practice

参考文献

关键文献

Wilkins BS. The spleen. Br J Haematol. 2002;117:265-274.

Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues: IARC WHO classification of tumours, No. 3. Washington, DC: IARC Press WHO; 2009.

Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008;112:3939-3948.

Schechter AN. Hemoglobin research and the origins of molecular medicine. Blood. 2008;112:3927-3938.

参考文章

1.  Lichtin AE, Cook JR. Diseases of the spleen. In: Young NS, Gerson SL, High KA, eds. Clinical hematology. 1st ed. Philadelphia, PA: Elsevier; 2006:697-705.

2.  Willner IR, Reuben A. Alcohol and the liver. Curr Opin Gastroenterol. 2005;21:323-330.

3.  Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma: long term follow-up of no initial therapy. J Clin Oncol. 2004;22:1454-1459.

4.  Koc O, Wilson WH. Non-Hodgkin's lymphoma. In: Young NS, Gerson SL, High KA, eds. Clinical hematology. 1st ed. Philadelphia, PA: Elsevier; 2006:579-595.

5.  Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004;104:3009-3020.

6.  Treon SP, Gertz MA, Dimopoulos M, et al. Update on treatment recommendations from the Third International Workshop on Waldenstrom's Macroglobulinemia. Blood. 2006;107:3442-3446.

7.  Wilkins BS. The spleen. Br J Haematol. 2002;117:265-274.

8.  Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues: IARC WHO classification of tumours, No. 3. Washington, DC: IARC Press WHO; 2009.

9.  Rawstron AC, Bennett FL, O'Conner SJM, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008;359:575-583.

10.  Cortes JE, Talpaz M, O'Brien S, et al. Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal. Cancer. 2006;106:1306-1315.

11.  Mughal TI, Goldman JM. Chronic myeloid leukemia: current status and controversies. Oncology. 2004;18:837-844.

12.  Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342:1255-1265.

13.  Tefferi A. JAK2 mutations in polycythemia vera: molecular mechanisms and clinical applications. N Engl J Med. 2007;356:444-445.

14.  Lachmann HJ, Goodman HJB, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356:2361-2371.

15.  Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124-131.

16.  Grabowski GA. Recent clinical progress in Gaucher disease. Curr Opin Pediatr. 2005;17:519-524.

17.  Imrie J, Vijayaraghaven S, Whitehouse C, et al. Niemann-Pick disease type C in adults. J Inherit Metab Dis. 2002;25:491-500.

18.  Griffith KS, Lewis LS, Mali S, et al. Treatment of malaria in the United States: a systematic review. JAMA. 2007;297:2264-2277.

19.  Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008;112:3939-3948.

20.  Schechter AN. Hemoglobin research and the origins of molecular medicine. Blood. 2008;112:3927-3938.

21.  Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J Med. 2006;354:2034-2045.

22.  Yung L, Linch D. Hodgkin's lymphoma. Lancet. 2003;361:943-951.

使用此内容应接受我们的免责声明